250 related articles for article (PubMed ID: 28385087)
1. Design, synthesis and evaluation of
Zhang Z; Lau J; Zhang C; Colpo N; Nocentini A; Supuran CT; Bénard F; Lin KS
J Enzyme Inhib Med Chem; 2017 Dec; 32(1):722-730. PubMed ID: 28385087
[TBL] [Abstract][Full Text] [Related]
2. Trimeric Radiofluorinated Sulfonamide Derivatives to Achieve In Vivo Selectivity for Carbonic Anhydrase IX-Targeted PET Imaging.
Lau J; Liu Z; Lin KS; Pan J; Zhang Z; Vullo D; Supuran CT; Perrin DM; Bénard F
J Nucl Med; 2015 Sep; 56(9):1434-40. PubMed ID: 26205302
[TBL] [Abstract][Full Text] [Related]
3. PET Imaging of Carbonic Anhydrase IX Expression of HT-29 Tumor Xenograft Mice with (68)Ga-Labeled Benzenesulfonamides.
Lau J; Zhang Z; Jenni S; Kuo HT; Liu Z; Vullo D; Supuran CT; Lin KS; Bénard F
Mol Pharm; 2016 Mar; 13(3):1137-46. PubMed ID: 26866675
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and evaluation of (18)F-labeled tertiary benzenesulfonamides for imaging carbonic anhydrase IX expression in tumours with positron emission tomography.
Lau J; Pan J; Zhang Z; Hundal-Jabal N; Liu Z; Bénard F; Lin KS
Bioorg Med Chem Lett; 2014 Jul; 24(14):3064-8. PubMed ID: 24878197
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and evaluation of 18F-labeled carbonic anhydrase IX inhibitors for imaging with positron emission tomography.
Pan J; Lau J; Mesak F; Hundal N; Pourghiasian M; Liu Z; Bénard F; Dedhar S; Supuran CT; Lin KS
J Enzyme Inhib Med Chem; 2014 Apr; 29(2):249-55. PubMed ID: 23463940
[TBL] [Abstract][Full Text] [Related]
6. Acetazolamide-based [
More KN; Lee JY; Kim DY; Cho NC; Pyo A; Yun M; Kim HS; Kim H; Ko K; Park JH; Chang DJ
Bioorg Med Chem Lett; 2018 Mar; 28(5):915-921. PubMed ID: 29422388
[TBL] [Abstract][Full Text] [Related]
7. Fluorine-18 click radiosynthesis and microPET/CT evaluation of a small peptide-a potential PET probe for carbonic anhydrase IX.
Jia L; Li X; Cheng D; Zhang L
Bioorg Med Chem; 2019 Mar; 27(5):785-789. PubMed ID: 30683555
[TBL] [Abstract][Full Text] [Related]
8. Synthesis of an acridine orange sulfonamide derivative with potent carbonic anhydrase IX inhibitory action.
Bragagni M; Carta F; Osman SM; AlOthman Z; Supuran CT
J Enzyme Inhib Med Chem; 2017 Dec; 32(1):701-706. PubMed ID: 28335646
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of
Nakai M; Pan J; Lin KS; Thompson JR; Nocentini A; Supuran CT; Nakabayashi Y; Storr T
J Inorg Biochem; 2018 Aug; 185():63-70. PubMed ID: 29778927
[TBL] [Abstract][Full Text] [Related]
10. PET imaging and pharmacological therapy targeting carbonic anhydrase-IX high-expressing tumors using US2 platform based on bivalent ureidosulfonamide.
Iikuni S; Watanabe H; Shimizu Y; Nakamoto Y; Ono M
PLoS One; 2020; 15(12):e0243327. PubMed ID: 33296398
[TBL] [Abstract][Full Text] [Related]
11. Targeting CAIX with [
Yang X; Zhu H; Yang X; Li N; Huang H; Liu T; Guo X; Xu X; Xia L; Deng C; Tian X; Yang Z
Mol Pharm; 2019 Apr; 16(4):1532-1540. PubMed ID: 30803240
[TBL] [Abstract][Full Text] [Related]
12. Synthesis and in Vivo Biological Evaluation of (68)Ga-Labeled Carbonic Anhydrase IX Targeting Small Molecules for Positron Emission Tomography.
Sneddon D; Niemans R; Bauwens M; Yaromina A; van Kuijk SJ; Lieuwes NG; Biemans R; Pooters I; Pellegrini PA; Lengkeek NA; Greguric I; Tonissen KF; Supuran CT; Lambin P; Dubois L; Poulsen SA
J Med Chem; 2016 Jul; 59(13):6431-43. PubMed ID: 27322137
[TBL] [Abstract][Full Text] [Related]
13. PEGylated Bis-Sulfonamide Carbonic Anhydrase Inhibitors Can Efficiently Control the Growth of Several Carbonic Anhydrase IX-Expressing Carcinomas.
Akocak S; Alam MR; Shabana AM; Sanku RK; Vullo D; Thompson H; Swenson ER; Supuran CT; Ilies MA
J Med Chem; 2016 May; 59(10):5077-88. PubMed ID: 27144971
[TBL] [Abstract][Full Text] [Related]
14. Design and synthesis of novel benzenesulfonamide containing 1,2,3-triazoles as potent human carbonic anhydrase isoforms I, II, IV and IX inhibitors.
Kumar R; Vats L; Bua S; Supuran CT; Sharma PK
Eur J Med Chem; 2018 Jul; 155():545-551. PubMed ID: 29909339
[TBL] [Abstract][Full Text] [Related]
15. Selective inhibition of human carbonic anhydrase IX in Xenopus oocytes and MDA-MB-231 breast cancer cells.
Kazokaitė J; Ames S; Becker HM; Deitmer JW; Matulis D
J Enzyme Inhib Med Chem; 2016; 31(sup4):38-44. PubMed ID: 27557419
[TBL] [Abstract][Full Text] [Related]
16. Development of the
Iikuni S; Tanimura K; Watanabe H; Shimizu Y; Saji H; Ono M
Mol Pharm; 2019 Apr; 16(4):1489-1497. PubMed ID: 30892905
[TBL] [Abstract][Full Text] [Related]
17. Design, synthesis and biological evaluation of novel pyridine-thiazolidinone derivatives as anticancer agents: Targeting human carbonic anhydrase IX.
Ansari MF; Idrees D; Hassan MI; Ahmad K; Avecilla F; Azam A
Eur J Med Chem; 2018 Jan; 144():544-556. PubMed ID: 29289880
[TBL] [Abstract][Full Text] [Related]
18. Synthesis, characterization and biological evaluation of tertiary sulfonamide derivatives of pyridyl-indole based heteroaryl chalcone as potential carbonic anhydrase IX inhibitors and anticancer agents.
Peerzada MN; Khan P; Ahmad K; Hassan MI; Azam A
Eur J Med Chem; 2018 Jul; 155():13-23. PubMed ID: 29852328
[TBL] [Abstract][Full Text] [Related]
19. Novel 2-(2-arylmethylthio-4-chloro-5-methylbenzenesulfonyl)-1-(1,3,5-triazin-2-ylamino)guanidine derivatives: Inhibition of human carbonic anhydrase cytosolic isozymes I and II and the transmembrane tumor-associated isozymes IX and XII, anticancer activity, and molecular modeling studies.
Żołnowska B; Sławiński J; Szafrański K; Angeli A; Supuran CT; Kawiak A; Wieczór M; Zielińska J; Bączek T; Bartoszewska S
Eur J Med Chem; 2018 Jan; 143():1931-1941. PubMed ID: 29146134
[TBL] [Abstract][Full Text] [Related]
20. Synthesis and evaluation of
Nakashima K; Iikuni S; Okada Y; Watanabe H; Shimizu Y; Nakamoto Y; Ono M
Nucl Med Biol; 2021 Feb; 93():46-53. PubMed ID: 33316738
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
